The New England Journal of Medicine has published the results from a rigorous randomized controlled trial in Kenya. Keheala, a digital health startup, helped reduce the unsuccessful treatment outcomes for tuberculosis (TB) patients by two-thirds.
Read MoreKeheala selected by World Bank Group and Brazilian healthcare providers for piloting opportunity.
Read More